Menu
/REGISTER
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Biotech  -  Page 2
Latest

Atara beats estimates with loss in Q1

By   /  Tuesday, May 4th, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Atara beats estimates with loss in Q1

Atara Biotherapeutics had a net loss of $78.2 million in the first quarter of fiscal year 2021, slightly higher compared than same quarter a year earlier, when the company had a loss of $73.5 million. Despite this, Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Read More →

Read More →
Latest

Thousand Oaks biotech firm closes $140M funding round

By   /  Thursday, April 29th, 2021  /  Biotech, East Ventura County, Latest news, Startups, Technology, Tri-County Economy  /  Comments Off on Thousand Oaks biotech firm closes $140M funding round

Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →

Read More →
Latest

Amgen stock tumbles after earnings report

By   /  Tuesday, April 27th, 2021  /  Banking & Finance, Biotech, Earnings, East Ventura County, middle, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen stock tumbles after earnings report

Editor’s note: This article was updated at 8:35 a.m. on April 28 with up-to-date information on Amgen’s stock price. Amgen’s shares fell nearly 8% following the company’s April 27 release of its first quarter 2021 earnings, which saw a decline in both revenue and net income compared to a year earlier. Amgen is headquartered in Read More →

Read More →
Latest

Amgen announces $721M acquisition

By   /  Tuesday, March 30th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, left, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen announces $721M acquisition

Amgen reported its second major acquisition of the month, as the Thousand Oaks-based firm announced March 30 that it will acquire Rodeo Therapeutics Corporation, a privately held biotech company based in Seattle. The deal is worth more than $700 million, $55 million of which will be paid upfront, with up to $666 million more in Read More →

Read More →
Latest

Our View: Life science industry merits state support

By   /  Friday, March 5th, 2021  /  Biotech, Editorials, Latest news, Opinion, Subscriber content  /  Comments Off on Our View: Life science industry merits state support

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen to buy cancer treatment biotech firm for $1.9B

By   /  Thursday, March 4th, 2021  /  Banking & Finance, Biotech, East Ventura County, Latest news, middle, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen to buy cancer treatment biotech firm for $1.9B

Thousand Oaks-based Amgen, one of the biggest biotech companies in the world, will get bigger with the $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotech company developing stomach cancer therapies. Amgen announced the acquisition March 4 and the deal is expected to close by the end of the second quarter of 2021. Under Read More →

Read More →
Latest

MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback

By   /  Thursday, February 25th, 2021  /  Banking & Finance, Biotech, Central Coast Health Watch, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback

MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →

Read More →